Zoom and Avaya announce new strategic partnership to deliver enhanced collaboration experiences 25-03-2024, 17:01

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

AS Ekspress Grupp to buy back its own shares 8-02-2023, 13:42